INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

Income tax expense for the years ended December 31, 2024, 2023 and 2022 consist of the following components:

	Altice USA						CSC Holdings
	Years Ended December 31,						Years Ended December 31,
	2024		2023		2022		2024		2023		2022
Current expense (benefit):
Federal	$	312,330	$	227,189	$	133,329	$	311,628	$	227,189	$	133,329
State	6,626		54,130		81,076		6,626		62,312		88,068
Foreign	—		105		128		—		105		128
	318,956		281,424		214,533		318,254		289,606		221,525
Deferred expense (benefit):
Federal	(321,244)		(210,378)		(43,797)		(321,245)		(210,378)		(43,797)
State	(74,872)		(16,547)		80,356		(78,370)		(21,680)		69,676
Foreign	64		10		(174)		64		10		(174)
	(396,052)		(226,915)		36,385		(399,551)		(232,048)		25,705
	(77,096)		54,509		250,918		(81,297)		57,558		247,230
Tax expense (benefit) relating to uncertain tax positions	73,025		(14,981)		44,922		73,025		(14,981)		44,922
Income tax expense (benefit)	$	(4,071)	$	39,528	$	295,840	$	(8,272)	$	42,577	$	292,152

Schedule of Effective Income Tax Rate Reconciliation

The income tax expense (benefit) attributable to operations differs from the amount derived by applying the statutory federal rate to pretax income (loss) principally due to the effect of the following items:

	Altice USA						CSC Holdings
	Years Ended December 31,						Years Ended December 31,
	2024		2023		2022		2024		2023		2022
Federal tax expense (benefit) at statutory rate	$	(17,293)	$	24,899	$	108,513	$	(17,995)	$	24,899	$	108,513
State income taxes, net of federal impact	(66,814)		6,436		26,527		(72,536)		9,842		28,768
Minority interest	(5,662)		(5,494)		(5,914)		(5,662)		(5,494)		(5,914)
Changes in the valuation allowance	5,598		13,847		20,176		7,821		14,099		15,494
Change in New York state rate to measure deferred taxes, net of federal impact	—		—		112,117		—		—		112,117
Other changes in the state rates used to measure deferred taxes, net of federal impact	(5,350)		23,909		(9,603)		(5,350)		23,300		(10,849)
Tax expense (benefit) relating to uncertain tax positions	63,941		(14,311)		36,281		63,941		(14,311)		36,281
Tax credits	(3,987)		(4,201)		(3,544)		(3,987)		(4,201)		(3,544)
Excess tax deficiencies related to share-based compensation including non-deductible carried unit plans	12,353		11,696		10,321		12,353		11,696		10,321
Non-deductible officers compensation	3,027		3,934		4,916		3,027		3,934		4,916
Foreign losses of disregarded entities	(8,361)		(6,097)		(6,352)		(8,361)		(6,097)		(6,352)
Business dispositions	—		(46,591)		—		—		(46,591)		—
Goodwill impairment and other permanent differences	16,887		34,241		—		16,887		34,241		—
Other, net	1,590		(2,740)		2,402		1,590		(2,740)		2,401
Income tax expense (benefit)	$	(4,071)	$	39,528	$	295,840	$	(8,272)	$	42,577	$	292,152

The following is the activity relating to our UTB reserve liability:

	Years Ended December 31,
	2024		2023		2022
Balance at beginning of year	$	53,010	$	70,593	$	25,296
Increases (decreases) from prior period positions	46,762		(18,714)		871
Increases from current period positions	15,117		1,131		44,426
Decreases relating to settlements with tax authorities	(524)		—		—
Balance at end of year	$	114,365	$	53,010	$	70,593

Schedule of Deferred Tax Assets and Liabilities

The tax effects of temporary differences which give rise to significant portions of deferred tax assets or liabilities and the corresponding valuation allowance are as follows:

	Altice USA				CSC Holdings
	December 31,				December 31,
	2024		2023		2024		2023
Noncurrent
NOLs, capital loss, and tax credit carry forwards (a)	$	129,444	$	130,134	$	109,103	$	104,071
Compensation and benefit plans	61,486		90,853		61,486		90,853
Restructuring liability	2,349		7,220		2,349		7,220
Other liabilities	21,482		50,440		21,482		50,440
Research and experimental expenditures	40,872		33,427		40,872		33,427
Interest deferred for tax purposes	781,826		536,284		781,826		536,284
Investments	1,516		1,519		1,516		1,519
Operating lease liability	74,773		79,263		74,773		79,263
Deferred tax assets	1,113,748		929,140		1,093,407		903,077
Less: Valuation allowance	(93,005)		(87,407)		(72,664)		(64,844)
Net deferred tax assets, noncurrent	1,020,743		841,733		1,020,743		838,233
Deferred tax liabilities:
Fixed assets and intangibles	(5,208,559)		(5,250,112)		(5,208,559)		(5,250,112)
Operating lease asset	(61,014)		(64,163)		(61,014)		(64,163)
Partnership investments	(185,473)		(173,198)		(185,473)		(173,198)
Prepaid expenses	(11,513)		(14,630)		(11,513)		(14,630)
Derivative contracts	(9,745)		(40,357)		(9,745)		(40,357)
Fair value adjustments related to debt and deferred financing costs	—		(1,751)		—		(1,751)
Opportunity Zone tax deferral	—		(145,655)		—		(145,655)
Deferred tax liability, noncurrent	(5,476,304)		(5,689,866)		(5,476,304)		(5,689,866)
Total net deferred tax liabilities	$	(4,455,561)	$	(4,848,133)	$	(4,455,561)	$	(4,851,633)